Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Related to this story

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA enforcement actions way down

By The Center for Public Integrity

Amid digital records surge, a lack of policing by the FDA

By Emma Schwartz and Fred Schulte

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Related to this story

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA lags USDA in accessible food safety data

By Jim Morris

Inspectors struggle to keep up with flood of imports

By Brad Racino

Amid digital records surge, a lack of policing by the FDA

By Emma Schwartz and Fred Schulte

Amid digital records surge, a lack of policing by the FDA

By Emma Schwartz and Fred Schulte

Government offers incentives to buy electronic devices it doesn't track for safety

Related to this story

FDA asks hospitals to report safety glitches in digital health systems

By Fred Schulte and Emma Schwartz

FDA, Obama digital medical records team at odds over safety oversight

By Fred Schulte and Emma Schwartz

FDA considers regulating safety of electronic health systems

By Fred Schulte and Emma Schwartz

Experts: Safety oversight needed as patient records go digital

By Fred Schulte and Emma Schwartz